Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Richez

Showing results (41-50 of 207) with videos related to

Pageof 21
Sort By:
Spine|November 15, 2011
Regression of giant cell tumor of the cervical spine with bisphosphonate as single therapyOlivier Gille, Bruno de Azevedo Oliveira, Patrick Guerin, et al.
Joint Bone Spine|September 25, 2016
Biotherapies in systemic lupus erythematosus: New targetsEstibaliz Lazaro, Marc Scherlinger, Marie-Elise Truchetet, et al.
Joint Bone Spine|September 25, 2010
Role for interferon regulatory factors in autoimmunityChristophe Richez, Thomas Barnetche, Corinne Miceli-Richard, et al.
Acta Dermato-Venereologica|May 27, 2021
Locoregional Treatments for Digital Ulcers in Systemic Sclerosis: A Systematic ReviewIngrid Costedoat, Maeva Masson, Thomas Barnetche, et al.
Drug Safety|March 23, 2025
Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety DatabaseRaffaella Di Napoli, Christophe Richez, Cristina Scavone, et al.
Drug Safety|April 22, 2025
Correction: Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety DatabaseRaffaella Di Napoli, Christophe Richez, Cristina Scavone, et al.
Plos One|April 12, 2013
The effect of mycophenolate mofetil on disease development in the gld.apoE (-/-) mouse model of accelerated atherosclerosis and systemic lupus erythematosusChristophe Richez, Rocco J Richards, Pierre Duffau, et al.
Clinical Rheumatology|January 15, 2016
Analysis of the effectiveness and safety of rituximab in patients with refractory lupus nephritis: a chart reviewAnne Contis, Helene Vanquaethem, Marie-Elise Truchetet, et al.
Joint Bone Spine|April 10, 2018
Hydroxychloroquine for the prevention of fetal growth restriction and prematurity in lupus pregnancy: A systematic review and meta-analysisVivien Guillotin, Alice Bouhet, Thomas Barnetche, et al.
The Journal of Rheumatology|April 3, 2012
Tocilizumab treatment decreases circulating myeloid dendritic cells and monocytes, 2 components of the myeloid lineageChristophe Richez, Thomas Barnetche, Liliane Khoryati, et al.
Pageof 21

Showing results (41-50 of 207) with videos related to

Sort By:
Pageof 21
Spine|November 15, 2011
Regression of giant cell tumor of the cervical spine with bisphosphonate as single therapyOlivier Gille, Bruno de Azevedo Oliveira, Patrick Guerin, et al.
Joint Bone Spine|September 25, 2016
Biotherapies in systemic lupus erythematosus: New targetsEstibaliz Lazaro, Marc Scherlinger, Marie-Elise Truchetet, et al.
Joint Bone Spine|September 25, 2010
Role for interferon regulatory factors in autoimmunityChristophe Richez, Thomas Barnetche, Corinne Miceli-Richard, et al.
Acta Dermato-Venereologica|May 27, 2021
Locoregional Treatments for Digital Ulcers in Systemic Sclerosis: A Systematic ReviewIngrid Costedoat, Maeva Masson, Thomas Barnetche, et al.
Drug Safety|March 23, 2025
Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety DatabaseRaffaella Di Napoli, Christophe Richez, Cristina Scavone, et al.
Drug Safety|April 22, 2025
Correction: Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety DatabaseRaffaella Di Napoli, Christophe Richez, Cristina Scavone, et al.
Plos One|April 12, 2013
The effect of mycophenolate mofetil on disease development in the gld.apoE (-/-) mouse model of accelerated atherosclerosis and systemic lupus erythematosusChristophe Richez, Rocco J Richards, Pierre Duffau, et al.
Clinical Rheumatology|January 15, 2016
Analysis of the effectiveness and safety of rituximab in patients with refractory lupus nephritis: a chart reviewAnne Contis, Helene Vanquaethem, Marie-Elise Truchetet, et al.
Joint Bone Spine|April 10, 2018
Hydroxychloroquine for the prevention of fetal growth restriction and prematurity in lupus pregnancy: A systematic review and meta-analysisVivien Guillotin, Alice Bouhet, Thomas Barnetche, et al.
The Journal of Rheumatology|April 3, 2012
Tocilizumab treatment decreases circulating myeloid dendritic cells and monocytes, 2 components of the myeloid lineageChristophe Richez, Thomas Barnetche, Liliane Khoryati, et al.
Pageof 21